N-acetylglucosamine reduces inflammatory response during acute peritonitis in uremic rats

A. Brȩborowicz, A. Potubinska, G. Wu, P. Tam, D. G. Oreopoulos

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Background: Peritoneal dialysis (PD) induces intraperitoneal inflammation and that process may be uremia. The goal of this study is to evaluate the effect of uremia on the kinetics of peritonitis and furthermore test the anti-inflammatory potential of N-acetylglucosamine (NAG) in a uremic environment. Methods: Experiments were performed on healthy Wistar rats and on animals with impaired renal function. Acute PD was performed in all animals with dialysis fluid conta in ing either glucose (GLU) or NAG as osmotic solutes. Peritonitis was induced by addition of lipopolysaccharide from Escherichia coli (LPS) to the dialysis fluid. Transperitoneal transport of water and solutes as well as intraperitoneal and systemic inflammation were evaluated. Results: Uremia reduces peritoneal permeability to total protein during peritonitis (-33% vs. control, p <0.001 ) and increases net ultrafiltration (+2.5 ±2.2 vs. -2.7 ±3.2 ml in control, p <0.001). In uremic rats with peritonitis, reduced dialy-sate levels of the following inflammatory mediators were detected as compared to healthy animals: MCP-1 (-15%, p <0.01); IL-1β (-53%, p <0.001), and elastase (-28%, p <0.02). In the serum of uremic rats, the increase in TNFα and MCP-1 concentrations was smaller than in control rats: -44% (p <0.02) and -39% (p <0.001 ), respectively. NAG used as an osmotic solute in rats with preserved renal function decreases intraperitoneal and systemic inflammation during acute peritonitis. Drained dialysate volume was increased in the NAG group by 32% (p <0.001) and transperitoneal loss of protein was reduced by 21% (p <0.002). When NAG was used as the osmotic solute instead of GLU, intraperitoneal inflammation in uremic animals was further reduced: TNFα (-40%, p <0.05); IL-1β (-49%, p <0.005); MCP-1 (-21%, p <0.005). The presence of NAG also reduced the increased blood level of IL-1β (-47%,p <0.02) and MCP-1 (-36%, p <0.02). Conclusions: Intensity of acute peritonitis is reduced during uremia. NAG exerts a systemic and peritoneal anti-inflammatory action under conditions of uremia that confirms the potential use of this compound as an osmotic agent in the PD fluids that also decreases inflammation.

Original languageEnglish (US)
Pages (from-to)274-281
Number of pages8
JournalBlood Purification
Volume24
Issue number3
DOIs
StatePublished - Apr 2006
Externally publishedYes

Fingerprint

Acetylglucosamine
Peritonitis
Uremia
Inflammation
Peritoneal Dialysis
Interleukin-1
Dialysis
Anti-Inflammatory Agents
Kidney
Glucose
Ascitic Fluid
Pancreatic Elastase
Dialysis Solutions
Ultrafiltration
Lipopolysaccharides
Wistar Rats
Permeability
Proteins
Escherichia coli
Water

Keywords

  • Glucose
  • N-Acetylglucosamine
  • Peritonitis
  • Renal failure

ASJC Scopus subject areas

  • Nephrology
  • Hematology

Cite this

Brȩborowicz, A., Potubinska, A., Wu, G., Tam, P., & Oreopoulos, D. G. (2006). N-acetylglucosamine reduces inflammatory response during acute peritonitis in uremic rats. Blood Purification, 24(3), 274-281. https://doi.org/10.1159/000091303

N-acetylglucosamine reduces inflammatory response during acute peritonitis in uremic rats. / Brȩborowicz, A.; Potubinska, A.; Wu, G.; Tam, P.; Oreopoulos, D. G.

In: Blood Purification, Vol. 24, No. 3, 04.2006, p. 274-281.

Research output: Contribution to journalArticle

Brȩborowicz, A, Potubinska, A, Wu, G, Tam, P & Oreopoulos, DG 2006, 'N-acetylglucosamine reduces inflammatory response during acute peritonitis in uremic rats', Blood Purification, vol. 24, no. 3, pp. 274-281. https://doi.org/10.1159/000091303
Brȩborowicz, A. ; Potubinska, A. ; Wu, G. ; Tam, P. ; Oreopoulos, D. G. / N-acetylglucosamine reduces inflammatory response during acute peritonitis in uremic rats. In: Blood Purification. 2006 ; Vol. 24, No. 3. pp. 274-281.
@article{1d5b9959a7a14fc48e71c47a485f24b6,
title = "N-acetylglucosamine reduces inflammatory response during acute peritonitis in uremic rats",
abstract = "Background: Peritoneal dialysis (PD) induces intraperitoneal inflammation and that process may be uremia. The goal of this study is to evaluate the effect of uremia on the kinetics of peritonitis and furthermore test the anti-inflammatory potential of N-acetylglucosamine (NAG) in a uremic environment. Methods: Experiments were performed on healthy Wistar rats and on animals with impaired renal function. Acute PD was performed in all animals with dialysis fluid conta in ing either glucose (GLU) or NAG as osmotic solutes. Peritonitis was induced by addition of lipopolysaccharide from Escherichia coli (LPS) to the dialysis fluid. Transperitoneal transport of water and solutes as well as intraperitoneal and systemic inflammation were evaluated. Results: Uremia reduces peritoneal permeability to total protein during peritonitis (-33{\%} vs. control, p <0.001 ) and increases net ultrafiltration (+2.5 ±2.2 vs. -2.7 ±3.2 ml in control, p <0.001). In uremic rats with peritonitis, reduced dialy-sate levels of the following inflammatory mediators were detected as compared to healthy animals: MCP-1 (-15{\%}, p <0.01); IL-1β (-53{\%}, p <0.001), and elastase (-28{\%}, p <0.02). In the serum of uremic rats, the increase in TNFα and MCP-1 concentrations was smaller than in control rats: -44{\%} (p <0.02) and -39{\%} (p <0.001 ), respectively. NAG used as an osmotic solute in rats with preserved renal function decreases intraperitoneal and systemic inflammation during acute peritonitis. Drained dialysate volume was increased in the NAG group by 32{\%} (p <0.001) and transperitoneal loss of protein was reduced by 21{\%} (p <0.002). When NAG was used as the osmotic solute instead of GLU, intraperitoneal inflammation in uremic animals was further reduced: TNFα (-40{\%}, p <0.05); IL-1β (-49{\%}, p <0.005); MCP-1 (-21{\%}, p <0.005). The presence of NAG also reduced the increased blood level of IL-1β (-47{\%},p <0.02) and MCP-1 (-36{\%}, p <0.02). Conclusions: Intensity of acute peritonitis is reduced during uremia. NAG exerts a systemic and peritoneal anti-inflammatory action under conditions of uremia that confirms the potential use of this compound as an osmotic agent in the PD fluids that also decreases inflammation.",
keywords = "Glucose, N-Acetylglucosamine, Peritonitis, Renal failure",
author = "A. Brȩborowicz and A. Potubinska and G. Wu and P. Tam and Oreopoulos, {D. G.}",
year = "2006",
month = "4",
doi = "10.1159/000091303",
language = "English (US)",
volume = "24",
pages = "274--281",
journal = "Blood Purification",
issn = "0253-5068",
publisher = "S. Karger AG",
number = "3",

}

TY - JOUR

T1 - N-acetylglucosamine reduces inflammatory response during acute peritonitis in uremic rats

AU - Brȩborowicz, A.

AU - Potubinska, A.

AU - Wu, G.

AU - Tam, P.

AU - Oreopoulos, D. G.

PY - 2006/4

Y1 - 2006/4

N2 - Background: Peritoneal dialysis (PD) induces intraperitoneal inflammation and that process may be uremia. The goal of this study is to evaluate the effect of uremia on the kinetics of peritonitis and furthermore test the anti-inflammatory potential of N-acetylglucosamine (NAG) in a uremic environment. Methods: Experiments were performed on healthy Wistar rats and on animals with impaired renal function. Acute PD was performed in all animals with dialysis fluid conta in ing either glucose (GLU) or NAG as osmotic solutes. Peritonitis was induced by addition of lipopolysaccharide from Escherichia coli (LPS) to the dialysis fluid. Transperitoneal transport of water and solutes as well as intraperitoneal and systemic inflammation were evaluated. Results: Uremia reduces peritoneal permeability to total protein during peritonitis (-33% vs. control, p <0.001 ) and increases net ultrafiltration (+2.5 ±2.2 vs. -2.7 ±3.2 ml in control, p <0.001). In uremic rats with peritonitis, reduced dialy-sate levels of the following inflammatory mediators were detected as compared to healthy animals: MCP-1 (-15%, p <0.01); IL-1β (-53%, p <0.001), and elastase (-28%, p <0.02). In the serum of uremic rats, the increase in TNFα and MCP-1 concentrations was smaller than in control rats: -44% (p <0.02) and -39% (p <0.001 ), respectively. NAG used as an osmotic solute in rats with preserved renal function decreases intraperitoneal and systemic inflammation during acute peritonitis. Drained dialysate volume was increased in the NAG group by 32% (p <0.001) and transperitoneal loss of protein was reduced by 21% (p <0.002). When NAG was used as the osmotic solute instead of GLU, intraperitoneal inflammation in uremic animals was further reduced: TNFα (-40%, p <0.05); IL-1β (-49%, p <0.005); MCP-1 (-21%, p <0.005). The presence of NAG also reduced the increased blood level of IL-1β (-47%,p <0.02) and MCP-1 (-36%, p <0.02). Conclusions: Intensity of acute peritonitis is reduced during uremia. NAG exerts a systemic and peritoneal anti-inflammatory action under conditions of uremia that confirms the potential use of this compound as an osmotic agent in the PD fluids that also decreases inflammation.

AB - Background: Peritoneal dialysis (PD) induces intraperitoneal inflammation and that process may be uremia. The goal of this study is to evaluate the effect of uremia on the kinetics of peritonitis and furthermore test the anti-inflammatory potential of N-acetylglucosamine (NAG) in a uremic environment. Methods: Experiments were performed on healthy Wistar rats and on animals with impaired renal function. Acute PD was performed in all animals with dialysis fluid conta in ing either glucose (GLU) or NAG as osmotic solutes. Peritonitis was induced by addition of lipopolysaccharide from Escherichia coli (LPS) to the dialysis fluid. Transperitoneal transport of water and solutes as well as intraperitoneal and systemic inflammation were evaluated. Results: Uremia reduces peritoneal permeability to total protein during peritonitis (-33% vs. control, p <0.001 ) and increases net ultrafiltration (+2.5 ±2.2 vs. -2.7 ±3.2 ml in control, p <0.001). In uremic rats with peritonitis, reduced dialy-sate levels of the following inflammatory mediators were detected as compared to healthy animals: MCP-1 (-15%, p <0.01); IL-1β (-53%, p <0.001), and elastase (-28%, p <0.02). In the serum of uremic rats, the increase in TNFα and MCP-1 concentrations was smaller than in control rats: -44% (p <0.02) and -39% (p <0.001 ), respectively. NAG used as an osmotic solute in rats with preserved renal function decreases intraperitoneal and systemic inflammation during acute peritonitis. Drained dialysate volume was increased in the NAG group by 32% (p <0.001) and transperitoneal loss of protein was reduced by 21% (p <0.002). When NAG was used as the osmotic solute instead of GLU, intraperitoneal inflammation in uremic animals was further reduced: TNFα (-40%, p <0.05); IL-1β (-49%, p <0.005); MCP-1 (-21%, p <0.005). The presence of NAG also reduced the increased blood level of IL-1β (-47%,p <0.02) and MCP-1 (-36%, p <0.02). Conclusions: Intensity of acute peritonitis is reduced during uremia. NAG exerts a systemic and peritoneal anti-inflammatory action under conditions of uremia that confirms the potential use of this compound as an osmotic agent in the PD fluids that also decreases inflammation.

KW - Glucose

KW - N-Acetylglucosamine

KW - Peritonitis

KW - Renal failure

UR - http://www.scopus.com/inward/record.url?scp=33744499456&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33744499456&partnerID=8YFLogxK

U2 - 10.1159/000091303

DO - 10.1159/000091303

M3 - Article

VL - 24

SP - 274

EP - 281

JO - Blood Purification

JF - Blood Purification

SN - 0253-5068

IS - 3

ER -